Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)

Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trends in molecular medicine 2021-04, Vol.27 (4), p.410-411
Hauptverfasser: Bar-Or, Amit, Pender, Michael P., Khanna, Rajiv, Steinman, Lawrence, Hartung, Hans-Peter, Maniar, Tap, Croze, Ed, Aftab, Blake T., Giovannoni, Gavin, Joshi, Manher A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 411
container_issue 4
container_start_page 410
container_title Trends in molecular medicine
container_volume 27
creator Bar-Or, Amit
Pender, Michael P.
Khanna, Rajiv
Steinman, Lawrence
Hartung, Hans-Peter
Maniar, Tap
Croze, Ed
Aftab, Blake T.
Giovannoni, Gavin
Joshi, Manher A.
description
doi_str_mv 10.1016/j.molmed.2021.01.004
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2491943932</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1471491421000356</els_id><sourcerecordid>2491943932</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-7dde8c911d8587621846eb70e71dcf93c5a4e5bc99c9f90d4e545b8e28ef3f8f3</originalsourceid><addsrcrecordid>eNp9kc9q3DAQxkVJSdI0b1CCjinUW_2zLe2h0IRtG0joodvSm_BK40SLLLuSHcgtlzxB3jBPUi1OeiwMSMP8Zob5PoTeUbKghFYft4uu9x3YBSOMLkgOIl6hQypqWgilfu_9-1NxgN6ktCWElnUt99EB5xWRjJND9LAa0gguPN0_njUx4l8uTgm7gK8mP7rBA_5hPMQ-ubTE6xvo4x1ugsWrDuK1C9f4ouum0I83EJvBQYZO1xGCnWf0Hszkm4ivwDrjAnzArFpyPCyZqgpOSc4JI-_fotdt4xMcP79H6OeX1fr8W3H5_evF-efLwnAux6K2FqRRlFpZyrpiVIoKNjWBmlrTKm7KRkC5MUoZ1SpicyLKjQQmoeWtbPkROp3nDrH_M0EadeeSAe-bAP2UNMtiKcEVZxkVM2ry8SlCq4fouibeaUr0zgC91bMBemeAJjmIyG0nzxumza720vSieAY-zQDkO28dRJ2Mg2CyQBHMqG3v_r_hL7JsmBE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2491943932</pqid></control><display><type>article</type><title>Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)</title><source>Access via ScienceDirect (Elsevier)</source><creator>Bar-Or, Amit ; Pender, Michael P. ; Khanna, Rajiv ; Steinman, Lawrence ; Hartung, Hans-Peter ; Maniar, Tap ; Croze, Ed ; Aftab, Blake T. ; Giovannoni, Gavin ; Joshi, Manher A.</creator><creatorcontrib>Bar-Or, Amit ; Pender, Michael P. ; Khanna, Rajiv ; Steinman, Lawrence ; Hartung, Hans-Peter ; Maniar, Tap ; Croze, Ed ; Aftab, Blake T. ; Giovannoni, Gavin ; Joshi, Manher A.</creatorcontrib><identifier>ISSN: 1471-4914</identifier><identifier>EISSN: 1471-499X</identifier><identifier>DOI: 10.1016/j.molmed.2021.01.004</identifier><identifier>PMID: 33608230</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>Trends in molecular medicine, 2021-04, Vol.27 (4), p.410-411</ispartof><rights>2018 The Authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c338t-7dde8c911d8587621846eb70e71dcf93c5a4e5bc99c9f90d4e545b8e28ef3f8f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.molmed.2021.01.004$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33608230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bar-Or, Amit</creatorcontrib><creatorcontrib>Pender, Michael P.</creatorcontrib><creatorcontrib>Khanna, Rajiv</creatorcontrib><creatorcontrib>Steinman, Lawrence</creatorcontrib><creatorcontrib>Hartung, Hans-Peter</creatorcontrib><creatorcontrib>Maniar, Tap</creatorcontrib><creatorcontrib>Croze, Ed</creatorcontrib><creatorcontrib>Aftab, Blake T.</creatorcontrib><creatorcontrib>Giovannoni, Gavin</creatorcontrib><creatorcontrib>Joshi, Manher A.</creatorcontrib><title>Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)</title><title>Trends in molecular medicine</title><addtitle>Trends Mol Med</addtitle><issn>1471-4914</issn><issn>1471-499X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc9q3DAQxkVJSdI0b1CCjinUW_2zLe2h0IRtG0joodvSm_BK40SLLLuSHcgtlzxB3jBPUi1OeiwMSMP8Zob5PoTeUbKghFYft4uu9x3YBSOMLkgOIl6hQypqWgilfu_9-1NxgN6ktCWElnUt99EB5xWRjJND9LAa0gguPN0_njUx4l8uTgm7gK8mP7rBA_5hPMQ-ubTE6xvo4x1ugsWrDuK1C9f4ouum0I83EJvBQYZO1xGCnWf0Hszkm4ivwDrjAnzArFpyPCyZqgpOSc4JI-_fotdt4xMcP79H6OeX1fr8W3H5_evF-efLwnAux6K2FqRRlFpZyrpiVIoKNjWBmlrTKm7KRkC5MUoZ1SpicyLKjQQmoeWtbPkROp3nDrH_M0EadeeSAe-bAP2UNMtiKcEVZxkVM2ry8SlCq4fouibeaUr0zgC91bMBemeAJjmIyG0nzxumza720vSieAY-zQDkO28dRJ2Mg2CyQBHMqG3v_r_hL7JsmBE</recordid><startdate>202104</startdate><enddate>202104</enddate><creator>Bar-Or, Amit</creator><creator>Pender, Michael P.</creator><creator>Khanna, Rajiv</creator><creator>Steinman, Lawrence</creator><creator>Hartung, Hans-Peter</creator><creator>Maniar, Tap</creator><creator>Croze, Ed</creator><creator>Aftab, Blake T.</creator><creator>Giovannoni, Gavin</creator><creator>Joshi, Manher A.</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202104</creationdate><title>Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)</title><author>Bar-Or, Amit ; Pender, Michael P. ; Khanna, Rajiv ; Steinman, Lawrence ; Hartung, Hans-Peter ; Maniar, Tap ; Croze, Ed ; Aftab, Blake T. ; Giovannoni, Gavin ; Joshi, Manher A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-7dde8c911d8587621846eb70e71dcf93c5a4e5bc99c9f90d4e545b8e28ef3f8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bar-Or, Amit</creatorcontrib><creatorcontrib>Pender, Michael P.</creatorcontrib><creatorcontrib>Khanna, Rajiv</creatorcontrib><creatorcontrib>Steinman, Lawrence</creatorcontrib><creatorcontrib>Hartung, Hans-Peter</creatorcontrib><creatorcontrib>Maniar, Tap</creatorcontrib><creatorcontrib>Croze, Ed</creatorcontrib><creatorcontrib>Aftab, Blake T.</creatorcontrib><creatorcontrib>Giovannoni, Gavin</creatorcontrib><creatorcontrib>Joshi, Manher A.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Trends in molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bar-Or, Amit</au><au>Pender, Michael P.</au><au>Khanna, Rajiv</au><au>Steinman, Lawrence</au><au>Hartung, Hans-Peter</au><au>Maniar, Tap</au><au>Croze, Ed</au><au>Aftab, Blake T.</au><au>Giovannoni, Gavin</au><au>Joshi, Manher A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)</atitle><jtitle>Trends in molecular medicine</jtitle><addtitle>Trends Mol Med</addtitle><date>2021-04</date><risdate>2021</risdate><volume>27</volume><issue>4</issue><spage>410</spage><epage>411</epage><pages>410-411</pages><issn>1471-4914</issn><eissn>1471-499X</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33608230</pmid><doi>10.1016/j.molmed.2021.01.004</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-4914
ispartof Trends in molecular medicine, 2021-04, Vol.27 (4), p.410-411
issn 1471-4914
1471-499X
language eng
recordid cdi_proquest_miscellaneous_2491943932
source Access via ScienceDirect (Elsevier)
title Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies: (Trends in Molecular Medicine, 26:3 p:296-310, 2020)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T01%3A28%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epstein%E2%80%93Barr%20Virus%20in%20Multiple%20Sclerosis:%20Theory%20and%20Emerging%20Immunotherapies:%20(Trends%20in%20Molecular%20Medicine,%2026:3%20p:296-310,%202020)&rft.jtitle=Trends%20in%20molecular%20medicine&rft.au=Bar-Or,%20Amit&rft.date=2021-04&rft.volume=27&rft.issue=4&rft.spage=410&rft.epage=411&rft.pages=410-411&rft.issn=1471-4914&rft.eissn=1471-499X&rft_id=info:doi/10.1016/j.molmed.2021.01.004&rft_dat=%3Cproquest_cross%3E2491943932%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2491943932&rft_id=info:pmid/33608230&rft_els_id=S1471491421000356&rfr_iscdi=true